Follistatin: Side Effects & Safety
Part of the Follistatin Complete Guide
Follistatin
We may earn a commission if you purchase through this link, at no extra cost to you.
Overall Safety Profile
Follistatin's safety profile for injectable research use is poorly characterized. Gene therapy studies (AAV-follistatin) in muscular dystrophy have shown a generally acceptable safety profile, but these use a fundamentally different delivery method. Injectable follistatin-344 lacks formal safety evaluation.
Potential Side Effects
- Reproductive effects: Follistatin inhibits activin, which regulates FSH — reproductive hormone disruption is possible
- Injection site reactions: Common with protein injections
- Immune response: Possible antibody formation against exogenous protein
Critical Limitations
No clinical trials of injectable follistatin for muscle growth in healthy humans exist. Long-term effects of chronic myostatin inhibition are unknown. TGF-β signaling has complex, context-dependent roles in cancer — both tumor-suppressive and tumor-promoting. Myostatin also has roles in cardiac tissue.
Potential Contraindications
- Active cancer (TGF-β pathway involvement)
- Cardiac conditions (myostatin affects cardiac tissue)
- Fertility concerns (activin/FSH disruption)
- Pregnancy and breastfeeding